AIM: To investigate the role of Beclin 1 on the susceptibility of HepG2 cells to undergo apoptosis after anti-Fas antibody or doxorubicin treatment. METHODS: Beclin 1 silencing was achieved using RNA interference. DNA ploidy, the percentage of apoptotic cells and the mitochondrial membrane potential were assessed by flow cytometry. Levels of Beclin 1, Bcl-X(L) and cytochrome c, and the cleavage of poly (ADP-ribose) polymerase (PARP) were assayed by using Western blots. RESULTS: Beclin 1 expression decreased by 75% 72 h after Beclin 1 siRNA transfection. Partial Beclin 1 silencing significantly increased the percentage of subG1 cells 24 and 40 h after treatment with doxorubicin or anti-Fas antibody, respectively, and this potentiation was abrogated by treatment with a pan-caspase inhibitor. Partial Beclin 1 silencing also increased PARP cleavage, mitochondrial membrane depolarization and cytosolic cytochrome c. The pro-apoptotic consequences of partial Beclin 1 silencing were not associated with a decline in Bcl-X(L) expression. CONCLUSION: Partial Beclin 1 silencing aggravates mitochondrial permeabilization and apoptosis in HepG2 cells treated with an anti-Fas antibody or with doxorubicin.
AIM: To investigate the role of Beclin 1 on the susceptibility of HepG2 cells to undergo apoptosis after anti-Fas antibody or doxorubicin treatment. METHODS:Beclin 1 silencing was achieved using RNA interference. DNA ploidy, the percentage of apoptotic cells and the mitochondrial membrane potential were assessed by flow cytometry. Levels of Beclin 1, Bcl-X(L) and cytochrome c, and the cleavage of poly (ADP-ribose) polymerase (PARP) were assayed by using Western blots. RESULTS:Beclin 1 expression decreased by 75% 72 h after Beclin 1 siRNA transfection. Partial Beclin 1 silencing significantly increased the percentage of subG1 cells 24 and 40 h after treatment with doxorubicin or anti-Fas antibody, respectively, and this potentiation was abrogated by treatment with a pan-caspase inhibitor. Partial Beclin 1 silencing also increased PARP cleavage, mitochondrial membrane depolarization and cytosolic cytochrome c. The pro-apoptotic consequences of partial Beclin 1 silencing were not associated with a decline in Bcl-X(L) expression. CONCLUSION: Partial Beclin 1 silencing aggravates mitochondrial permeabilization and apoptosis in HepG2 cells treated with an anti-Fas antibody or with doxorubicin.
Authors: A J Minn; C S Kettlun; H Liang; A Kelekar; M G Vander Heiden; B S Chang; S W Fesik; M Fill; C B Thompson Journal: EMBO J Date: 1999-02-01 Impact factor: 11.598
Authors: J L Diaz; T Oltersdorf; W Horne; M McConnell; G Wilson; S Weeks; T Garcia; L C Fritz Journal: J Biol Chem Date: 1997-04-25 Impact factor: 5.157
Authors: V M Aita; X H Liang; V V Murty; D L Pincus; W Yu; E Cayanis; S Kalachikov; T C Gilliam; B Levine Journal: Genomics Date: 1999-07-01 Impact factor: 5.736
Authors: L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson Journal: Cell Date: 1993-08-27 Impact factor: 41.582
Authors: Li Yu; Ajjai Alva; Helen Su; Parmesh Dutt; Eric Freundt; Sarah Welsh; Eric H Baehrecke; Michael J Lenardo Journal: Science Date: 2004-05-06 Impact factor: 47.728
Authors: Efthimios Sivridis; Michael I Koukourakis; Christos E Zois; Ioanna Ledaki; David J P Ferguson; Adrian L Harris; Kevin C Gatter; Alexandra Giatromanolaki Journal: Am J Pathol Date: 2010-04-09 Impact factor: 4.307
Authors: Claire M Payne; Cheray Crowley-Skillicorn; Hana Holubec; Katerina Dvorak; Carol Bernstein; Mary Pat Moyer; Harinder Garewal; Harris Bernstein Journal: J Toxicol Date: 2009-05-10
Authors: Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S Ryerse; Ratna B Ray; Ranjit Ray Journal: J Virol Date: 2007-12-12 Impact factor: 5.103
Authors: Yan Cheng; Ugir Hossain Sk; Yi Zhang; Xingcong Ren; Li Zhang; Kathryn J Huber-Keener; Yuan-Wan Sun; Jason Liao; Shantu Amin; Arun K Sharma; Jin-Ming Yang Journal: PLoS One Date: 2012-04-05 Impact factor: 3.240